Redwood Park Advisors LLC
Position in ACRV — Acrivon Therapeutics, Inc.
CIK 2056274
Redwood City, CA
Position in ACRV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$890
+$195 QoQ
Shares Held
500
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 46 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ACRV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Redwood Park Advisors LLC holds $178,983 across 7 Biotechnology names. ACRV ranks #4 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
415 | $131,177 | |
| 2 | SANA |
Sana Biotechnology, Inc.
|
7,140 | $24,918 | |
| 3 | VERA |
Vera Therapeutics, Inc.
|
500 | $21,455 | |
| 4 | ACRV |
Acrivon Therapeutics, Inc.
This page
|
500 | $890 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1 | $496 | |
| 6 | FLNA |
Filana Therapeutics, Inc.
|
40 | $47 | |
| 7 | OABIW |
OmniAb, Inc.
|
2,184 | $0 |
All Filings in ACRV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $890 | 500 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $695 | 500 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,205 | 500 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $905 | 500 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $595 | 500 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $1,015 | 500 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $3,010 | 500 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||